The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 Mar 2021
Historique:
received: 16 06 2020
accepted: 18 01 2021
entrez: 11 4 2021
pubmed: 12 4 2021
medline: 24 4 2021
Statut: epublish

Résumé

The early identification of factors that predict the length of hospital stay (HS) in patients affected by coronavirus desease (COVID-19) might assist therapeutic decisions and patient flow management. We collected, at the time of admission, routine clinical, laboratory, and imaging parameters of hypoxia, lung damage, inflammation, and organ dysfunction in a consecutive series of 50 COVID-19 patients admitted to the Respiratory Disease and Infectious Disease Units of the University Hospital of Sassari (North-Sardinia, Italy) and alive on discharge. Prolonged HS (PHS, >21 days) patients had significantly lower PaO2/FiO2 ratio and lymphocytes, and significantly higher Chest CT severity score, C-reactive protein (CRP) and lactic dehydrogenase (LDH) when compared to non-PHS patients. In univariate logistic regression, Chest CT severity score (OR = 1.1891, p = 0.007), intensity of care (OR = 2.1350, p = 0.022), PaO2/FiO2 ratio (OR = 0.9802, p = 0.007), CRP (OR = 1.0952, p = 0.042) and platelet to lymphocyte ratio (OR = 1.0039, p = 0.036) were significantly associated with PHS. However, in multivariate logistic regression, only the PaO2/FiO2 ratio remained significantly correlated with PHS (OR = 0.9164; 95% CI 0.8479-0.9904, p = 0.0275). In ROC curve analysis, using a threshold of 248, the PaO2/FiO2 ratio predicted PHS with sensitivity and specificity of 60% and 91%, respectively (AUC = 0.780, 95% CI 0.637-0.886 p = 0.002). The PaO2/FiO2 ratio on admission is independently associated with PHS in COVID-19 patients. Larger prospective studies are needed to confirm this finding.

Identifiants

pubmed: 33839709
doi: 10.3855/jidc.13288
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

353-359

Informations de copyright

Copyright (c) 2021 Angelo Zinellu, Andrea De Vito, Valentina Scano, Panagiotis Paliogiannis, Vito Fiore, Giordano Madeddu, Ivana Maida, Elisabetta Zinellu, Arduino Aleksander Mangoni, Luigi Benedetto Arru, Ciriaco Carru, Sergio Babudieri, Pietro Pirina, Alessandro Giuseppe Fois.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Angelo Zinellu (A)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Andrea De Vito (A)

Infectious and Tropical Diseases Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Valentina Scano (V)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Panagiotis Paliogiannis (P)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Vito Fiore (V)

Infectious and Tropical Diseases Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Giordano Madeddu (G)

Infectious and Tropical Diseases Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Ivana Maida (I)

Infectious and Tropical Diseases Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Elisabetta Zinellu (E)

Unit of Respiratory Diseases, University Hospital Sassari (AOU), Sassari, Italy.

Arduino Aleksander Mangoni (AA)

Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Adelaide, Australia.

Luigi Benedetto Arru (LB)

Operative Unit of Hematology, Center for Stem Cell Transplantation, San Francesco Hospital, Nuoro, Italy.

Ciriaco Carru (C)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Sergio Babudieri (S)

Infectious and Tropical Diseases Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Pietro Pirina (P)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Alessandro Giuseppe Fois (AG)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. agfois@uniss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH